Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin + Pomalidomide + Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01979276Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Nov 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in multiple myeloma (MM), sponsored by Weill Cornell Medicine. Started Nov 2013; status: terminated.
02
Drugs
romidepsin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01979276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979276.